colorbar.png
We're hiring!

FastFinder

A software platform that automates the
last part of your PCR workflow

PCR analyses are hard.

Even when every step of the analysis prior to interpretation is executed perfectly, human error can and will occur. The data is ambiguous, different cyclers, different assays... Managing QA and standardizing procedures is increasingly difficult.

With volumes increasing each year, laboratory scientists are occupied with repetitive work and seemingly endless analysis of clear positives and negatives. Scientists should only have to deal with curves that require real interpretation.

difficult_transp.gif
bg_image_laboratories.png

A PCR software.

Built for laboratories.
With laboratories.

FastFinder is the result of a simple observation. We use software for everything in our lives. Yet for a lab that runs routine PCR tests, there is no real software solution that encompasses the entire interpretation process.

Enter FastFinder. A software that automatically translates raw PCR-data into a list of clearly defined true positives and true negatives. You can finally lift the diagnostic certainty of your lab developed tests or tests on (semi-)open systems to the level of a closed system.

Molecular labs 

Competitive assays.

Need automated software.

Distributing assays without software is impossible. Yet developing & validating a software is not within the expertise of diagnostic companies.

FastFinder is the perfect way to add value to your assays. Once set up, our software can interpret the results your assays generate automatically. We can take our out of the box solution and customize it to your bidding on short notice. And it doesn't have to be expensive, avoid large amounts of overhead costs and pay per analysis.

Diagnostic companies
software_for_assays.png

UgenTec

Not your average bio-IT company.

UgenTec was founded in 2014 by Tom Martens & Wouter Uten. The company is a spin-off from the University of Leuven (KUL). Located in Corda Campus, Hasselt, it has successfully completed several investment rounds.

The company is backed by market-savvy investors & continues its international expansion.

The team consists of 18 people and includes top level data scientists, developers, biologists & business developers. It differentiates itself by really understanding the language of the diagnostic market while delivering state-of-the-art software.

Company
not_an_average_bio-IT_company.png

Stay in the know...
Subscribe to our newsletter.

Trusted and supported by: